Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Fampridine-SR: Began Phase II testing

Acorda Therapeutics Inc., Hawthorne, N.Y.
Product: Fampridine-SR
Business: Neurological

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE